Virtus Lifesci Biotech Etf Performance

BBP Etf  USD 56.38  0.92  1.66%   
The entity has a beta of 1.4, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Virtus LifeSci will likely underperform.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Virtus LifeSci Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Virtus LifeSci is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
1
Where are the Opportunities in - Stock Traders Daily
02/07/2024
2
Explore B2Brokers New 5M Brokerage Platform that Elevates Crypto Spot Trading
03/25/2024
In Threey Sharp Ratio0.10
  

Virtus LifeSci Relative Risk vs. Return Landscape

If you would invest  5,809  in Virtus LifeSci Biotech on December 29, 2023 and sell it today you would lose (171.00) from holding Virtus LifeSci Biotech or give up 2.94% of portfolio value over 90 days. Virtus LifeSci Biotech is generating negative expected returns assuming volatility of 1.4942% on return distribution over 90 days investment horizon. In other words, 13% of etfs are less volatile than Virtus, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Virtus LifeSci is expected to under-perform the market. In addition to that, the company is 2.61 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 per unit of volatility.

Virtus LifeSci Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Virtus LifeSci's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Virtus LifeSci Biotech, and traders can use it to determine the average amount a Virtus LifeSci's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0254

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBBP

Estimated Market Risk

 1.49
  actual daily
13
87% of assets are more volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Virtus LifeSci is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding Virtus LifeSci to a well-diversified portfolio.

Virtus LifeSci Fundamentals Growth

Virtus Etf prices reflect investors' perceptions of the future prospects and financial health of Virtus LifeSci, and Virtus LifeSci fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Virtus Etf performance.

About Virtus LifeSci Performance

To evaluate Virtus LifeSci Biotech Etf as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Virtus LifeSci generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Virtus Etf's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Virtus LifeSci Biotech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Virtus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
Virtus LifeSci generated a negative expected return over the last 90 days
Latest headline from seekingalpha.com: First Trust Alerian Disruptive Technology Real Estate ETF declares 0.0311 dividend
The fund holds 98.73% of its assets under management (AUM) in equities
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Virtus Etf analysis

When running Virtus LifeSci's price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.